{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T12:41:38Z","timestamp":1782564098476,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81870622"],"award-info":[{"award-number":["81870622"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004735","name":"Hunan Provincial Natural Science Foundation of China","doi-asserted-by":"crossref","award":["2022JJ30828"],"award-info":[{"award-number":["2022JJ30828"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hunan Provincial Clinical Medicine Research Center for Intelligent Management of Chronic Disease","award":["2023SK4042"],"award-info":[{"award-number":["2023SK4042"]}]},{"name":"Hunan Provincial Health High-level Talents Program, Postgraduate Innovative Project of Central South University","award":["2023XQLH033"],"award-info":[{"award-number":["2023XQLH033"]}]},{"DOI":"10.13039\/501100010083","name":"Hunan Provincial Innovation Foundation For Postgraduate","doi-asserted-by":"crossref","award":["CX20240301"],"award-info":[{"award-number":["CX20240301"]}],"id":[{"id":"10.13039\/501100010083","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Project of Hunan Provincial Health Commission","award":["C202303067096"],"award-info":[{"award-number":["C202303067096"]}]},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["GX2021B04"],"award-info":[{"award-number":["GX2021B04"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Osteoporos Rep"],"DOI":"10.1007\/s11914-025-00948-9","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T04:58:13Z","timestamp":1768193893000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Atypical Femoral Fractures Induced by Anti-Resorptive Medications"],"prefix":"10.1007","volume":"24","author":[{"given":"Yanyan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueqing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifeng","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"issue":"6","key":"948_CR1","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/0002-9343(93)90218-e","volume":"94","author":"Consensus development conference","year":"1993","unstructured":"Consensus development conference. diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646\u201350. https:\/\/doi.org\/10.1016\/0002-9343(93)90218-e.","journal-title":"Am J Med"},{"issue":"3","key":"948_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s0749-0690(02)00022-8","volume":"18","author":"M Srivastava","year":"2002","unstructured":"Srivastava M, Deal C. Osteoporosis in elderly: prevention and treatment. Clin Geriatr Med. 2002;18(3):529\u201355. https:\/\/doi.org\/10.1016\/s0749-0690(02)00022-8.","journal-title":"Clin Geriatr Med"},{"issue":"Suppl 6","key":"948_CR3","first-page":"S164","volume":"17","author":"DW Dempster","year":"2011","unstructured":"Dempster DW. Osteoporosis and the burden of osteoporosis-related fractures. Am J Manag Care. 2011;17(Suppl 6):S164\u20139.","journal-title":"Am J Manag Care"},{"issue":"10329","key":"948_CR4","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/s0140-6736(21)02646-5","volume":"399","author":"IR Reid","year":"2022","unstructured":"Reid IR, Billington EO. Drug therapy for osteoporosis in older adults. Lancet. 2022;399(10329):1080\u201392. https:\/\/doi.org\/10.1016\/s0140-6736(21)02646-5.","journal-title":"Lancet"},{"issue":"5","key":"948_CR5","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1210\/jc.2019-00192","volume":"104","author":"P Barrionuevo","year":"2019","unstructured":"Barrionuevo P, Kapoor E, Asi N, Alahdab F, Mohammed K, Benkhadra K, et al. Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis. J Clin Endocrinol Metab. 2019;104(5):1623\u201330. https:\/\/doi.org\/10.1210\/jc.2019-00192.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"948_CR6","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1210\/jc.2019-00221","volume":"104","author":"R Eastell","year":"2019","unstructured":"Eastell R, Rosen CJ, Black DM, Cheung AM, Murad MH, Shoback D. Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline. J Clin Endocrinol Metab. 2019;104(5):1595\u2013622. https:\/\/doi.org\/10.1210\/jc.2019-00221.","journal-title":"J Clin Endocrinol Metab"},{"issue":"21","key":"948_CR7","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1056\/NEJMcp2307353","volume":"389","author":"MD Walker","year":"2023","unstructured":"Walker MD, Shane E. Postmenopausal osteoporosis. N Engl J Med. 2023;389(21):1979\u201391. https:\/\/doi.org\/10.1056\/NEJMcp2307353.","journal-title":"N Engl J Med"},{"issue":"1","key":"948_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, et al. Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014;29(1):1\u201323. https:\/\/doi.org\/10.1002\/jbmr.1998.","journal-title":"J Bone Miner Res"},{"issue":"14","key":"948_CR9","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.160450","volume":"189","author":"AA Khan","year":"2017","unstructured":"Khan AA, Kaiser S. Atypical femoral fracture. CMAJ. 2017;189(14):E542. https:\/\/doi.org\/10.1503\/cmaj.160450.","journal-title":"CMAJ"},{"issue":"1","key":"948_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12603-015-0652-3","volume":"21","author":"KS Khow","year":"2017","unstructured":"Khow KS, Shibu P, Yu SC, Chehade MJ, Visvanathan R. Epidemiology and postoperative outcomes of atypical femoral fractures in older adults: a systematic review. J Nutr Health Aging. 2017;21(1):83\u201391. https:\/\/doi.org\/10.1007\/s12603-015-0652-3.","journal-title":"J Nutr Health Aging"},{"issue":"2","key":"948_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00198-010-1453-5","volume":"22","author":"R Rizzoli","year":"2011","unstructured":"Rizzoli R, Akesson K, Bouxsein M, Kanis JA, Napoli N, Papapoulos S, et al. Subtrochanteric fractures after long-term treatment with bisphosphonates: a European society on clinical and economic aspects of osteoporosis and osteoarthritis, and international osteoporosis foundation working group report. Osteoporos Int. 2011;22(2):373\u201390. https:\/\/doi.org\/10.1007\/s00198-010-1453-5.","journal-title":"Osteoporos Int"},{"issue":"6","key":"948_CR12","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bone.2011.09.042","volume":"49","author":"CK Tjhia","year":"2011","unstructured":"Tjhia CK, Odvina CV, Rao DS, Stover SM, Wang X, Fyhrie DP. Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects. Bone. 2011;49(6):1279\u201389. https:\/\/doi.org\/10.1016\/j.bone.2011.09.042.","journal-title":"Bone"},{"issue":"8","key":"948_CR13","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS, et al. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383(8):743\u201353. https:\/\/doi.org\/10.1056\/NEJMoa1916525.","journal-title":"N Engl J Med"},{"issue":"7","key":"948_CR14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/s2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML, Brown JP, Chapurlat R, Cummings SR, et al. 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol. 2017;5(7):513\u201323. https:\/\/doi.org\/10.1016\/s2213-8587(17)30138-9.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"948_CR15","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1302\/2058-5241.3.170070","volume":"3","author":"MS Larsen","year":"2018","unstructured":"Larsen MS, Schmal H. The enigma of atypical femoral fractures: a summary of current knowledge. EFORT Open Rev. 2018;3(9):494\u2013500. https:\/\/doi.org\/10.1302\/2058-5241.3.170070.","journal-title":"EFORT Open Rev"},{"key":"948_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115453","volume":"137","author":"Y Oh","year":"2020","unstructured":"Oh Y, Yamamoto K, Hashimoto J, Fujita K, Yoshii T, Fukushima K, et al. Biological activity is not suppressed in mid-shaft stress fracture of the bowed femoral shaft unlike in \u201ctypical\u201d atypical subtrochanteric femoral fracture: a proposed theory of atypical femoral fracture subtypes. Bone. 2020;137:115453. https:\/\/doi.org\/10.1016\/j.bone.2020.115453.","journal-title":"Bone"},{"issue":"22","key":"948_CR17","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1056\/NEJMc2029828","volume":"383","author":"SM Ott","year":"2020","unstructured":"Ott SM, Heckbert SR. Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med. 2020;383(22):2188\u20139. https:\/\/doi.org\/10.1056\/NEJMc2029828.","journal-title":"N Engl J Med"},{"issue":"7","key":"948_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.3420","volume":"33","author":"AL Adams","year":"2018","unstructured":"Adams AL, Adams JL, Raebel MA, Tang BT, Kuntz JL, Vijayadeva V, et al. Bisphosphonate drug holiday and fracture risk: a population-based cohort study. J Bone Miner Res. 2018;33(7):1252\u20139. https:\/\/doi.org\/10.1002\/jbmr.3420.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"948_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.7326\/m22-0684","volume":"176","author":"C Ayers","year":"2023","unstructured":"Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C. Effectiveness and safety of treatments to prevent fractures in people with low bone mass or primary osteoporosis: a living systematic review and network meta-analysis for the American College of Physicians. Ann Intern Med. 2023;176(2):182\u201395. https:\/\/doi.org\/10.7326\/m22-0684.","journal-title":"Ann Intern Med"},{"key":"948_CR20","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"Lo JC, Hui RL, Grimsrud CD, Chandra M, Neugebauer RS, Gonzalez JR, et al. The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016;85:142\u20137. https:\/\/doi.org\/10.1016\/j.bone.2016.01.002.","journal-title":"Bone"},{"key":"948_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115319","volume":"135","author":"HH Nguyen","year":"2020","unstructured":"Nguyen HH, Lakhani A, Shore-Lorenti C, Zebaze R, Vincent AJ, Milat F, et al. Asian ethnicity is associated with atypical femur fractures in an Australian population study. Bone. 2020;135:115319. https:\/\/doi.org\/10.1016\/j.bone.2020.115319.","journal-title":"Bone"},{"issue":"10","key":"948_CR22","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1056\/NEJMc1403799","volume":"371","author":"J Schilcher","year":"2014","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K. Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014;371(10):974\u20136. https:\/\/doi.org\/10.1056\/NEJMc1403799.","journal-title":"N Engl J Med"},{"issue":"1","key":"948_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/jbmr\/zjae175","volume":"40","author":"W Zhou","year":"2024","unstructured":"Zhou W, van de Laarschot DM, van Rooij JGJ, Koedam M, Nguyen HH, Uitterlinden AG, et al. Family-based whole-exome sequencing implicates a variant in lysyl oxidase like 4 in atypical femur fractures. J Bone Miner Res. 2024;40(1):69\u201378. https:\/\/doi.org\/10.1093\/jbmr\/zjae175.","journal-title":"J Bone Miner Res"},{"issue":"2","key":"948_CR24","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1210\/er.2018-00001","volume":"40","author":"DM Black","year":"2019","unstructured":"Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N. Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management. Endocr Rev. 2019;40(2):333\u201368. https:\/\/doi.org\/10.1210\/er.2018-00001.","journal-title":"Endocr Rev"},{"key":"948_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ph16040626","author":"S Toriumi","year":"2023","unstructured":"Toriumi S, Mimori R, Sakamoto H, Sueki H, Yamamoto M, Uesawa Y. Examination of risk factors and expression patterns of atypical femoral fractures using the Japanese Adverse Drug Event Report database: a retrospective pharmacovigilance study. Pharmaceuticals (Basel). 2023. https:\/\/doi.org\/10.3390\/ph16040626.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"11","key":"948_CR26","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","volume":"28","author":"JH Koh","year":"2017","unstructured":"Koh JH, Myong JP, Yoo J, Lim YW, Lee J, Kwok SK, et al. <article-title update=\"added\">Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8\u00a0years\u2019 experience in a single center. Osteoporos Int. 2017;28(11):3251\u20139. https:\/\/doi.org\/10.1007\/s00198-017-4169-y.","journal-title":"Osteoporos Int"},{"issue":"11","key":"948_CR27","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1002\/jbmr.4705","volume":"37","author":"F Cosman","year":"2022","unstructured":"Cosman F, Huang S, McDermott M, Cummings SR. Multiple vertebral fractures after denosumab discontinuation: FREEDOM and FREEDOM extension trials additional post hoc analyses. J Bone Miner Res. 2022;37(11):2112\u201320. https:\/\/doi.org\/10.1002\/jbmr.4705.","journal-title":"J Bone Miner Res"},{"key":"948_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/srep43399","volume":"7","author":"S Ma","year":"2017","unstructured":"Ma S, Goh EL, Jin A, Bhattacharya R, Boughton OR, Patel B, et al. Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties. Sci Rep. 2017;7:43399. https:\/\/doi.org\/10.1038\/srep43399.","journal-title":"Sci Rep"},{"issue":"5","key":"948_CR29","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"T Mashiba","year":"2001","unstructured":"Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB. Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone. 2001;28(5):524\u201331.","journal-title":"Bone"},{"issue":"4","key":"948_CR30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/2040622315584114","volume":"6","author":"Y Saita","year":"2015","unstructured":"Saita Y, Ishijima M, Kaneko K. Atypical femoral fractures and bisphosphonate use: current evidence and clinical implications. Ther Adv Chronic Dis. 2015;6(4):185\u201393.","journal-title":"Ther Adv Chronic Dis"},{"issue":"1","key":"948_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bone.2010.10.159","volume":"49","author":"MR Allen","year":"2011","unstructured":"Allen MR, Burr DB. Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don\u2019t know. Bone. 2011;49(1):56\u201365. https:\/\/doi.org\/10.1016\/j.bone.2010.10.159.","journal-title":"Bone"},{"key":"948_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.115850","volume":"145","author":"PR Jensen","year":"2021","unstructured":"Jensen PR, Andersen TL, Chavassieux P, Roux JP, Delaisse JM. Bisphosphonates impair the onset of bone formation at remodeling sites. Bone. 2021;145:115850. https:\/\/doi.org\/10.1016\/j.bone.2021.115850.","journal-title":"Bone"},{"issue":"1","key":"948_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.bone.2010.08.008","volume":"49","author":"T Bellido","year":"2011","unstructured":"Bellido T, Plotkin LI. Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability. Bone. 2011;49(1):50\u20135. https:\/\/doi.org\/10.1016\/j.bone.2010.08.008.","journal-title":"Bone"},{"issue":"1","key":"948_CR34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00223-019-00546-9","volume":"105","author":"M Kharazmi","year":"2019","unstructured":"Kharazmi M, Micha\u00eblsson K, Schilcher J, Eriksson N, Melhus H, Wadelius M, et al. A genome-wide association study of bisphosphonate-associated atypical femoral fracture. Calcif Tissue Int. 2019;105(1):51\u201367. https:\/\/doi.org\/10.1007\/s00223-019-00546-9.","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"948_CR35","doi-asserted-by":"publisher","first-page":"127","DOI":"10.5371\/hp.2017.29.2.127","volume":"29","author":"H Yoo","year":"2017","unstructured":"Yoo H, Cho Y, Park Y, Ha S. Lateral femoral bowing and the location of atypical femoral fractures. Hip Pelvis. 2017;29(2):127\u201332. https:\/\/doi.org\/10.5371\/hp.2017.29.2.127.","journal-title":"Hip Pelvis"},{"issue":"4","key":"948_CR36","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s00776-014-0572-9","volume":"19","author":"Y Oh","year":"2014","unstructured":"Oh Y, Wakabayashi Y, Kurosa Y, Ishizuki M, Okawa A. Stress fracture of the bowed femoral shaft is another cause of atypical femoral fracture in elderly Japanese: a case series. J Orthop Sci. 2014;19(4):579\u201386. https:\/\/doi.org\/10.1007\/s00776-014-0572-9.","journal-title":"J Orthop Sci"},{"issue":"1","key":"948_CR37","first-page":"29","volume":"14","author":"HM Karaka\u015f","year":"2008","unstructured":"Karaka\u015f HM, Harma A. Femoral shaft bowing with age: a digital radiological study of Anatolian Caucasian adults. Diagn Interv Radiol. 2008;14(1):29\u201332.","journal-title":"Diagn Interv Radiol"},{"issue":"2","key":"948_CR38","doi-asserted-by":"publisher","DOI":"10.1177\/2309499019848778","volume":"27","author":"A Hammer","year":"2019","unstructured":"Hammer A. The calcar femorale: a new perspective. J Orthop Surg (Hong Kong). 2019;27(2):2309499019848778. https:\/\/doi.org\/10.1177\/2309499019848778.","journal-title":"J Orthop Surg (Hong Kong)"},{"issue":"1","key":"948_CR39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016;31(1):16\u201335. https:\/\/doi.org\/10.1002\/jbmr.2708.","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"948_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/gl-2020-0524suppl","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, Diab DL, Eldeiry LS, Farooki A, et al. American association of clinical endocrinologists\/American college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl 1):1\u201346. https:\/\/doi.org\/10.4158\/gl-2020-0524suppl.","journal-title":"Endocr Pract"},{"issue":"1","key":"948_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40520-024-02826-3","volume":"36","author":"N Veronese","year":"2024","unstructured":"Veronese N, Briot K, Gua\u00f1abens N, Albergaria BH, Alokail M, Al-Daghri N, et al. Recommendations for the optimal use of bone forming agents in osteoporosis. Aging Clin Exp Res. 2024;36(1):167. https:\/\/doi.org\/10.1007\/s40520-024-02826-3.","journal-title":"Aging Clin Exp Res"},{"key":"948_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115431","volume":"138","author":"J Pfeilschifter","year":"2020","unstructured":"Pfeilschifter J, Steinebach I, Trampisch HJ, Rudolf H. Bisphosphonate drug holidays: risk of fractures and mortality in a prospective cohort study. Bone. 2020;138:115431. https:\/\/doi.org\/10.1016\/j.bone.2020.115431.","journal-title":"Bone"},{"key":"948_CR43","doi-asserted-by":"publisher","unstructured":"American Geriatrics Society 2019 updated AGS beers criteria\u00ae for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2019;67(4):674\u201394. https:\/\/doi.org\/10.1111\/jgs.15767.","DOI":"10.1111\/jgs.15767"},{"key":"948_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10051140","author":"KN Hayes","year":"2021","unstructured":"Hayes KN, Winter EM, Cadarette SM, Burden AM. Duration of bisphosphonate drug holidays in osteoporosis patients: a narrative review of the evidence and considerations for decision-making. J Clin Med. 2021. https:\/\/doi.org\/10.3390\/jcm10051140.","journal-title":"J Clin Med"},{"issue":"4","key":"948_CR45","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1007\/s00198-018-4791-3","volume":"30","author":"S Nayak","year":"2019","unstructured":"Nayak S, Greenspan SL. A systematic review and meta-analysis of the effect of bisphosphonate drug holidays on bone mineral density and osteoporotic fracture risk. Osteoporos Int. 2019;30(4):705\u201320. https:\/\/doi.org\/10.1007\/s00198-018-4791-3.","journal-title":"Osteoporos Int"},{"issue":"5","key":"948_CR46","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/jbmr.3654","volume":"34","author":"TY Kim","year":"2019","unstructured":"Kim TY, Bauer DC, McNabb BL, Schafer AL, Cosman F, Black DM, et al. Comparison of BMD changes and bone formation marker levels 3 years after bisphosphonate discontinuation: FLEX and HORIZON-PFT extension I trials. J Bone Miner Res. 2019;34(5):810\u20136. https:\/\/doi.org\/10.1002\/jbmr.3654.","journal-title":"J Bone Miner Res"},{"issue":"3","key":"948_CR47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3949\/ccjm.90a.22071","volume":"90","author":"TS Khan","year":"2023","unstructured":"Khan TS, Sinha P, Rosen H. To repeat or not to repeat? Measuring bone mineral density during anti-resorptive therapy or a drug holiday. Cleve Clin J Med. 2023;90(3):173\u201380. https:\/\/doi.org\/10.3949\/ccjm.90a.22071.","journal-title":"Cleve Clin J Med"},{"issue":"7","key":"948_CR48","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1002\/jbmr.4305","volume":"36","author":"AS S\u00f8lling","year":"2021","unstructured":"S\u00f8lling AS, Harsl\u00f8f T, Langdahl B. Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study. J Bone Miner Res. 2021;36(7):1245\u201354. https:\/\/doi.org\/10.1002\/jbmr.4305.","journal-title":"J Bone Miner Res"},{"issue":"5","key":"948_CR49","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, Sullivan JK, et al. Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov. 2012;11(5):401\u201319. https:\/\/doi.org\/10.1038\/nrd3705.","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"948_CR50","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11914-022-00771-6","volume":"21","author":"AS S\u00f8lling","year":"2023","unstructured":"S\u00f8lling AS, Tsourdi E, Harsl\u00f8f T, Langdahl BL. Denosumab discontinuation. Curr Osteoporos Rep. 2023;21(1):95\u2013103. https:\/\/doi.org\/10.1007\/s11914-022-00771-6.","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"948_CR51","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1302\/0301-620x.99b3.Bjj-2016-0276.R2","volume":"99-b","author":"A Koh","year":"2017","unstructured":"Koh A, Guerado E, Giannoudis PV. Atypical femoral fractures related to bisphosphonate treatment: issues and controversies related to their surgical management. Bone Joint J. 2017;99-b(3):295\u2013302. https:\/\/doi.org\/10.1302\/0301-620x.99b3.Bjj-2016-0276.R2.","journal-title":"Bone Joint J"},{"issue":"11","key":"948_CR52","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1359\/jbmr.2003.18.11.1932","volume":"18","author":"Y Jiang","year":"2003","unstructured":"Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF. Recombinant human parathyroid hormone (1\u201334) [teriparatide] improves both cortical and cancellous bone structure. J Bone Miner Res. 2003;18(11):1932\u201341. https:\/\/doi.org\/10.1359\/jbmr.2003.18.11.1932.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"948_CR53","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/BOT.0b013e31828e13fe","volume":"28","author":"D Zhang","year":"2014","unstructured":"Zhang D, Potty A, Vyas P, Lane J. The role of recombinant PTH in human fracture healing: a systematic review. J Orthop Trauma. 2014;28(1):57\u201362. https:\/\/doi.org\/10.1097\/BOT.0b013e31828e13fe.","journal-title":"J Orthop Trauma"}],"container-title":["Current Osteoporosis Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11914-025-00948-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11914-025-00948-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:25:30Z","timestamp":1768472730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11914-025-00948-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1007\/s11914-025-00948-9","relation":{},"ISSN":["1544-2241"],"issn-type":[{"value":"1544-2241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}],"article-number":"2"}}